Additional file 4: of MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design

Table S4. Amino acid sequences of predicted MHC Class II molecule HLA DRB1 binding neo-peptides in 147 lung adenocarcinoma patients in this study. (XLSX 503 kb